ロード中...
Serial QuantiFERON-TB Gold testing in patients with psoriasis treated with ustekinumab
BACKGROUND: There is increasing concern about the risk of latent tuberculosis infection (LTBI) reactivation during the use of biologics for psoriasis. Although ustekinumab had been documented with low risk of tuberculosis, the long-term follow-up of LTBI as determined by QuantiFERON-TB Gold (QFT-G)...
保存先:
| 出版年: | PLoS One |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5590912/ https://ncbi.nlm.nih.gov/pubmed/28886099 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0184178 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|